Managing Negative Symptoms of Schizophrenia: Oxford Psychiatry Library
Editat de István Bitteren Limba Engleză Paperback – 9 apr 2020
Din seria Oxford Psychiatry Library
- 16% Preț: 255.30 lei
- 15% Preț: 211.51 lei
- 11% Preț: 238.78 lei
- 10% Preț: 216.67 lei
- 16% Preț: 254.29 lei
- 11% Preț: 241.02 lei
- 9% Preț: 226.18 lei
- 14% Preț: 171.61 lei
- 10% Preț: 215.69 lei
- 32% Preț: 181.82 lei
- 29% Preț: 242.61 lei
- 12% Preț: 150.87 lei
- 16% Preț: 228.24 lei
- 16% Preț: 275.74 lei
- 10% Preț: 295.94 lei
- 11% Preț: 240.41 lei
- 16% Preț: 226.18 lei
- 10% Preț: 243.34 lei
- 14% Preț: 192.61 lei
- 16% Preț: 239.09 lei
Preț: 240.60 lei
Preț vechi: 286.05 lei
-16% Nou
Puncte Express: 361
Preț estimativ în valută:
46.05€ • 47.83$ • 38.25£
46.05€ • 47.83$ • 38.25£
Carte tipărită la comandă
Livrare economică 22-28 ianuarie 25
Livrare express 27 decembrie 24 - 02 ianuarie 25 pentru 54.18 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780198840121
ISBN-10: 0198840128
Pagini: 144
Dimensiuni: 139 x 211 x 8 mm
Greutate: 0.21 kg
Editura: OUP OXFORD
Colecția OUP Oxford
Seria Oxford Psychiatry Library
Locul publicării:Oxford, United Kingdom
ISBN-10: 0198840128
Pagini: 144
Dimensiuni: 139 x 211 x 8 mm
Greutate: 0.21 kg
Editura: OUP OXFORD
Colecția OUP Oxford
Seria Oxford Psychiatry Library
Locul publicării:Oxford, United Kingdom
Notă biografică
István Bitter, MD., PhD., DSc. is Professor of the Department of Psychiatry and Psychotherapy at Semmelweis University in Budapest, Hungary. A graduate of Semmelweis University, he is board-certified as a Specialist in Neurology, Psychiatry, Psychotherapy, and Clinical Pharmacology. He worked in Austria and Germany, and was visiting professor at the New York University Department of Psychiatry and research scientist at N.S. Kline Institute for Psychiatric Research in the USA. His current research focuses on schizophrenia, ADHD, clinical psychopharmacology, and epidemiology, including the use of "real world data". Dr. Bitter is a founding member of the European Group for Research in Schizophrenia, co-chair of the ECNP Network for Schizophrenia, chair of the EPA Section of Psychopharmacology, and a member of the Executive Board of the National Brain Research Program in Hungary.